Vietnam Ensures Medicine Supply Amid Global Conflicts | Drug Administration Issues Urgent Guidelines
Hanoi – Vietnam’s Department of Drug Administration has issued directives to health departments nationwide, hospitals, and pharmaceutical manufacturers regarding the maintenance of adequate drug supplies amid escalating geopolitical instability, particularly in the Middle East. The move, detailed in a notice published by Bao Lao Cai newspaper, aims to proactively safeguard the availability of medications for both routine medical care and emergency treatment.
The directive instructs provincial and municipal health departments to closely monitor drug supply conditions within their jurisdictions and promptly report any potential shortages or disruptions in the supply of pharmaceuticals and pharmaceutical raw materials. Hospitals and other healthcare facilities dependent on the Ministry of Health are also tasked with proactively reviewing their inventories of medications and raw materials, assessing supplier capabilities, and developing appropriate stockpiling plans, with a specific focus on essential drugs for emergency care.
Pharmaceutical manufacturers, exporters, and importers are required to develop proactive plans for production, importation, and storage of drugs and raw materials. These plans should specifically address potential market fluctuations and supply chain disruptions. The Department of Drug Administration emphasized the require to ensure a continuous supply of medications even in the face of external pressures.
The Vietnamese government’s concern stems from the potential for international conflicts to disrupt the global supply chain, impacting the availability of both finished pharmaceutical products and the raw materials needed for their production. While the notice specifically references tensions in the Middle East, it does not detail specific anticipated impacts.
The Department of Drug Administration has requested that any units anticipating drug shortages or supply difficulties submit detailed information for review and potential escalation to the Ministry of Health for guidance. The Ministry of Health in Ecuador, through its National Directorate of Regulation of Medicines and Medical Devices, maintains a similar focus on drug availability, as outlined on its website. The Panamanian Ministry of Health also actively promotes health and wellness information through its digital magazine, Salud y Bienestar, though it does not directly address supply chain concerns in publicly available information. Similarly, DIGEMID, the General Directorate of Medicines, Supplies and Drugs of Peru’s Ministry of Health, recently announced a course focused on optimizing antimicrobial use, indicating a broader commitment to pharmaceutical management.
As of Tuesday, March 24, 2026, the Department of Drug Administration has not publicly announced any specific shortages or disruptions. The department has not indicated a timeline for a follow-up assessment of the situation or a public report on the implementation of these directives.